Parliamentary data shows 104 NAION cases and thousands treated for gallstones, though it doesn't prove the drugs caused them. Doctors left 97% of flagged scripts unchanged.
Recap by typeshit. Full story at Korea Biomedical Review.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A surgeon on social media says the FDA has received two death reports involving black-market retatrutide. No official FDA statement is linked.
Approved on the 7th after a Phase 3 trial showing 9.75% average weight loss. Observers expect the lowest dose could cost around 100,000 won a month.
Fridges that can hold medication and higher-protein menus are among the new requests Fast Company highlights from the Priceline findings.
Loading…